Reduction of Sulindac to its active metabolite, sulindac sulfide: Assay and role of the methionine sulfoxide reductase system

Biochemical and Biophysical Research Communications

Volumn 312, Issue 4, 2003, Pages 1005-1010

  Etienne, Frantzy ^a   Resnick, Lionel ^a   Sagher, Daphna ^a   Brot, Nathan ^b   Weissbach, Herbert ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Methionine sulfoxide reductase; Sulindac; Sulindac sulfide

Indexed keywords

METHIONINE SULFOXIDE; OXIDOREDUCTASE; SULINDAC; SULINDAC SULFIDE;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BRAIN; CATTLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; KIDNEY; LIVER; MICROSOME; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; REDUCTION; TISSUE DISTRIBUTION;

ESCHERICHIA COLI;

EID: 0345357813     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.10.203     Document Type: Article

References (47)

1. Weissbach H., Etienne F., Hoshi T., Heinemann S.H., Lowther W.T., Matthews B., St. John G., Nathan C., Brot N. Peptide methionine sulfoxide reductase: structure, mechanism of action, and biological function. Arch. Biochem. Biophys. 397(2):2002;172-178.
2. Moskovitz J., Flescher E., Berlett B.S., Azare J.A., Poston M., Stadtman E.R. Overexpression of peptide methionine sulfoxide reductase (MsrA) in Saccharomyces cerevisiae and human T-cells provide them with high resistance with oxidative stress. Proc. Natl. Acad. Sci. USA. 95:1998;14071-14075.
3. Brot N., Weissbach L., Werth J., Weissbach H. Enzymatic reduction of protein-bound methionine sulfoxide. Proc. Natl. Acad. Sci. USA. 78:1981;2155-2158.
4. Rahman M.A., Nelson H., Weissbach H., Brot N. Cloning, sequencing, and expression of the Escherichia coli peptide methionine sulfoxide reductase gene. J. Biol. Chem. 267:1992;15549-15551.
5. Lowther W.T., Brot N., Weissbach H., Matthews B.W. Structure and mechanism of methionine sulfoxide reductase, an "anti-oxidation" enzyme. Biochemistry. 39:2000;13307-13312.
6. Moskovitz J., Weissbach H., Brot N. Cloning and expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc. Natl. Acad. Sci. USA. 93:1996;2095-2099.
7. Sharov V.S., Ferrington D.A., Squier T.C., Schoneich C. Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase. FEBS Lett. 455:1999;247-250.
8. Moskovitz J., Poston M., Berlett B.S., Nosworthy J.N., Szczepanowski R., Stadtman E.R. Identification and characterization of a putative active site for peptide methionine sulfoxide reductase (MsrA) and its substrate stereospecificity. J. Biol. Chem. 275:2000;14167-14172.
9. Grimaud R., Ezraty B., Mitchell J.K., Lafitte D., Briand C., Derrick P.J., Barras F. Repair of oxidized proteins: identification of a new methionine sulfoxide reductase. J. Biol. Chem. 276:2001;48915-48920.
10. Lowther W.T., Weissbach H., Etienne F., Brot N., Matthews B.W. The "mirrored" methionine sulfoxide reductases of Neisseria gonorrhoeae pilB. Nat. Struct. Biol. 9(5):2002;348-352.
11. Orly A., Boschi-Muller S., Marrand M., Sanglier-Cianferani S., Van Dorsselear A., Branlant G. Characterization of the methionine sufoxide reductase activities of pilB, a probable virulence factor from Neisseria meningitides. J. Biol. Chem. 277:2002;12022-12106.
12. Moskovitz J., Singh V.K., Requena J., Wilkinson B.J., Jayaswal R.K., Stadtman E.R. Purification and characterization of methionine sulfoxide reductases from mouse and Staphylococcus aureus and their substrate stereospecificity. Biochem. Biophys. Res. Commun. 290:2002;62-65.
13. Kryukov G.V., Kumara A., Koc A., Sun Z., Gladyshev V.N. Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide reductase. Proc. Natl. Acad. Sci. USA. 99:2002;4245-4250.
14. Etienne F., Spector D., Brot N., Weissbach H. A methionine sulfoxide reductase in Escherichia coli that reduces the R enantiomer of methionine sulfoxide. Biochem. Biophys. Res. Commun. 300:2003;378-382.
15. Spector D., Etienne F., Brot N., Weissbach H. New membrane associated and soluble peptide methionine sulfoxide reductases in Escherichia coli. Biochem. Biophys. Res. Commun. 302:2003;284-289.
16. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:1971;232-235.
17. Duggan D.E., Hooke K.F., Risley E.A., Shen T.Y., Van Arman C.G. Identification of the biologically active form of sulindac. J. Pharmacol. Expr. Therapeut. 201:1977;8-13.
18. Taketo M.M. Cyclooxygenase-2 inhibitors in tumorigenesis (part 1). J. Natl. Cancer Inst. 90:1998;1529-1536.
19. Taketo M.M. Cyclooxygenase-2 inhibitors in tumorigenesis (part 2). J. Natl. Cancer Inst. 90:1998;1609-1620.
20. Gwyn K., Sinicrope F.A. Chemoprevention of colorectal cancer. Am. J. Gastroenterol. 97:2002;13-21.
21. Janne P.A., Mayer R.J. Chemoprevention of colorectal cancer. N. Engl. J. Med. 342:2000;1960-1968.
22. Boolbol S.K., Dannenberg A.J., Chadburn A., Martucci C., Guo X.J., Ramonetti J.T., Abreu-Goris M., Newmark H.L., Lipkin M.L., DeCosse J.J., Bertagnolli M.M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56:1996;2556-2560.
23. Yamazaki R., Kusunoki N., Matsuzaki T., Hashimoto S., Kawai S. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells. FEBS Lett. 531:2002;278-284.
24. Richter M., Weiss M., Weinberger I., Furstenberger G., Marian B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis. 22:2001;17-25.
25. Tegeder I., Pfeilschifter J., Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15:2001;2057-2072.
26. Grosch S., Tegeder I., Niederberger E., Brautigam L., Geisslinger G. Cox-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective cox-2 inhibitor celecoxib. FASEB J. 15:2001;2742-2744.
27. Vogt T., McClelland M., Jung B., Popova S., Bogenrieder T., Becker B., Rumpler G., Landthaler M., Stolz W. Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II. Melanoma Res. 11:2001;587-599.
28. Zhang X., Morham S.G., Langenbach R., Young D.A. Malignant transformation and antineoplastic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J. Exp. Med. 190:1999;451-459.
29. Williams C.S., Goldman A.P., Sheng H., Morrow J.D., DuBois R.N. Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth. Neoplasia. 1:1999;170-176.
30. Wick M., Hurteau G., Dessev C., Chan D., Geraci M.W., Winn R.A., Heasley L.E., Nemenoff R.A. Peroxisome proliferator-activated receptor-g is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth. Mol. Pharmacol. 62:2002;1207-1214.
31. Shiff S.J., Qiao L., Tsai L.L., Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96:1995;491-503.
32. Picariello L., Brandi M.L., Formigli L., Orlandini S.Z., Dolara P., Caderni G., Raimondi L., Tonelli F. Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. Eur. J. Pharmacol. 360:1998;105-112.
33. Bauvy C., Gane P., Arico S., Codogno P., Ogier-Denis E. Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp. Cell Res. 268:2001;139-149.
34. Huang Y., He Q., Hillman M.J., Rong R., Sheikh M.S. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Mol. Biol. Gen. 61(18):2001;6918-6924.
35. Ravi R., Bedi A. Requirement for BAX for TRAIL/ Apo2L-induced apoptosis of colorectal cancers. Cancer Res. 62:2002;1583-1587.
36. Bonnesen C., Eggleston I.M., Hayes J.D. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in colon cell lines. Cancer Res. 61:2001;6120-6130.
37. Shirin H., Pinto J.T., Kawabata Y., Soh J.W., Delohery T., Moss S.F., Murty V., Rivlin R.S., Holt P.R., Weinstein I.B. Antiproliferative effects of S-allymercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Res. 61:2001;725-731.
38. Bottone F.G. Jr., Martinez J.M., Collins J.B., Afshari C.A., Eling T.E. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells. Biol. Chem. 278:2003;25790-25801.
39. Brot N., Werth J., Koster D., Weissbach H. Reduction of N-acetyl methionine sulfoxide: a simple assay for peptide methionine sulfoxide reductase. Anal. Biochem. 122:1982;291-294.
40. Lavine F.T. The formation, resolution and optical properties of the diastereoisometric sulfoxides derived from L-methionine. J. Biol. Chem. 169:1947;477-491.
41. Minetti G., Balduin C., Brovelli A. Reduction of DABS-L-methionine-DL- sulfoxide by protein methionine sulfoxide reductase from polymorphonuclear leukocytes: stereospecificity towards the L-sulfoxide. Ital. J. Biochem. 43:1994;273-283.
42. Rahman M.A., Brot N., Weissbach H. High level expression and purification of peptide methionine sulfoxide reductase in Escherichia coli. Cell. Mol. Biol. 38:1992;529-542.
43. Hansel A., Kuschel L., Hehl S., Lemke C., Agricola H.J., Hoshi T., Heinemann S.H. Mitochondrial targeting of the human peptide methionine sulfoxide reductase (MSRA), an enzyme involved in the repair of oxidized proteins. FASEB J. 16:2002;911-913.
44. Vougier S., Mary J., Friguet B. Subcellular localization of methionine sulfoxide reductase A (MsrA): evidence for mitochondrial and cytosolic isoforms in rat liver cells. Biochem. J. 373:2003;531-537.
45. Moskovitz J., Jenkins N., Gilbert D.J., Copeland N.G., Jursky F., Weissbach H., Brot N. Chromosomal localization of the mammalian peptide methionine sulfoxide reductase gene and its differential expression in various tissues. Proc. Natl. Acad. Sci. USA. 93:1996;3205-3208.
46. Jung S., Hansel A., Kasperczyk H., Hoshi T., Heinemann S.H. Activity, tissue, distribution and site-directed mutagenesis of a human peptide methionine sulfoxide reductase of type B: hCBS1. FEBS Lett. 527:2002;91-94.
47. Huang W., Escribano J., Sarfarazi M., Coca-Prados M. Identification, expression and chromosome localization of a human gene encoding a novel protein with similarity to the pilB family of transcriptional factors (pilin) and to bacterial peptide methionine sulfoxide reductases. Gene. 233:1999;233-240.